Guest Bloggers

  • Louisa Benton

    Executive Director

  • Steven P. Roose, M.D

    Professor of Clinical Psychiatry

  • Huda Akil, Ph.D

    DTF Chair

What is Acetyl-L-Carnitine? Depression linked to low levels of brain molecule,
September 5, 2018

A major study funded by Hope for Depression Research Foundation (HDRF) at Rockefeller University has revealed that a compound known as Acetyl-L-Carnitine (LAC) may be a biomarker for depression — a discovery that could lead to a potential blood test for depression.

Click here to read the full article…

HDRF Depression Task Force: Researchers’ Exciting New Findings,
October 5, 2017

Since 2012, the acclaimed researchers of HDRF’s Depression Task Force (DTF) have worked tirelessly to better understand the brain biology of depression in order to develop a new type of anti-depressant, one that works differently from the 20-plus drugs already on the market. Finding a new option is crucial, since 50% of patients do not respond fully to available anti-depressants.

Click here to read the full article…

Ketamine, a New Hope for Depression?,
September 21, 2017

The August issue of Time Magazine features a cover story on depression and one of the latest developments in treatment: ketamine hydrochloride.

We’ve received many inquiries about the controversial new drug and want to share important perspectives from our research team.

Click here to read the full article…

The New Yorker Declares HDRF Study a 2015 Standout,
January 12, 2016

We’re thrilled to announce that The New Yorker has named a recent HDRF study as one of the six most interesting psychology findings of the year.

The study was conducted by Dr. Huda Akil, Chair of our acclaimed Depression Task Force.  Her lab at U Michigan has identified a new brain protein that could point the way to new and better treatments for depression. The protein is called Fibroblast Growth Factor 9.

Click here to read the full article…

New Study Reveals Tip of the Iceberg,
December 18, 2015

Depression cuts a wide swath across society.

A new study released this month from Harvard Medical School reveals that the entire medical profession is even concerned about depression in its own ranks. Nearly 30% of new physicians struggle with severe symptoms of major depression, the study says. This is a rate three times worse than the general population.

Click here to read the full article…